Financial Comparison: Luxottica Group (LUXTY) & Its Competitors

Risk and Volatility

Luxottica Group has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Comparatively, Luxottica Group’s competitors have a beta of 2.49, suggesting that their average share price is 149% more volatile than the S&P 500.

Profitability

This table compares Luxottica Group and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Luxottica Group	N/A	N/A	N/A
Luxottica Group Competitors	-274.93%	-159.54%	-22.23%

Earnings & Valuation

This table compares Luxottica Group and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Luxottica Group	$10.34 billion	$1.17 billion	24.37
Luxottica Group Competitors	$1.89 billion	$142.73 million	8.39

Luxottica Group has higher revenue and earnings than its competitors. Luxottica Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

0.1% of Luxottica Group shares are owned by institutional investors. Comparatively, 39.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 75.0% of Luxottica Group shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Dividends

Luxottica Group pays an annual dividend of $0.91 per share and has a dividend yield of 1.6%. Luxottica Group pays out 39.7% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.3% and pay out 44.0% of their earnings in the form of a dividend.

Summary

Luxottica Group beats its competitors on 8 of the 11 factors compared.

Luxottica Group Company Profile

Luxottica Group S.p.A., together with its subsidiaries, provides fashion, luxury, sports, and performance eyewear worldwide. It operates through two segments, Manufacturing and Wholesale Distribution, and Retail Distribution. The Manufacturing and Wholesale Distribution segment engages in the design, manufacture, distribution, and marketing of proprietary and designer lines of prescription frames and sunglasses. This segment offers its products under proprietary brands, such as Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli, Arnette, and Vogue Eyewear; and licensed brands, including Giorgio Armani, Emporio Armani, Armani Exchange, Brooks Brothers, Burberry, Bulgari, Chanel, Coach, Dolce&Gabbana, DKNY, Michael Kors, Paul Smith Spectacles, Prada, Miu Miu, Ralph Lauren, Polo Ralph Lauren, Ralph, Starck Eyes, Tiffany & Co, Tory Burch, Valentino, Versace, and Ferrari. The Retail Distribution segment operates prescription eyewear stores primarily under its retail brands, including LensCrafters, Sunglass Hut, Pearle Vision, OPSM, Laubman & Pank, GMO, David Clulow, Salmoiraghi & Viganò, Ray-Ban, Oakley and Vault, Oliver Peoples, Alain Mikli, Ilori Optical, and Optical Shop of Aspen; and licensed brands, such as Sears Optical and Target Optical. As of December 31, 2017, it operated approximately 9,000 stores. The company was founded in 1961 and is headquartered in Milan, Italy. As of October 1, 2018, Luxottica Group S.p.A. operates as a subsidiary of EssilorLuxottica.